CLASS I Drug recall · Reported 14 Apr 2021 · FDA Enforcement Report

Telmisartan Tablets, USP 20 mg recalled by Alembic Pharmaceuticals

Alembic Pharmaceuticals is recalling Telmisartan Tablets, USP 20 mg, distributed nationwide in the US. The recall was initiated on 17 Mar 2021 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot #: 1905005661, Exp March 2022
NDC62332-087, 62332-088, 62332-089
UPC0362332087303, 0362332088300, 0362332089307
Quantity recalled12288 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0326-2021
FDA event ID
87533
Recalling firm
Alembic Pharmaceuticals, Tajpura, N/A
Manufacturer
Alembic Pharmaceuticals Inc.
Classification
Class I
Status
Terminated
Recall initiated
17 Mar 2021
FDA classified
7 Apr 2021
Reported
14 Apr 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

17 Mar 2021Recall initiated by company
7 Apr 2021Classified by FDA+21 days
14 Apr 2021Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Label-mixup

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 38935, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807, NDC 62332-087-30

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Is Telmisartan Tablets, USP 20 mg recalled?

Yes. Alembic Pharmaceuticals recalled Telmisartan Tablets, USP 20 mg on 17 Mar 2021. The recall is Class I and its status is Terminated. Recall number D-0326-2021.

Why was it recalled?

Labeling: Label-mixup

Which lots are affected?

Lot #: 1905005661, Exp March 2022

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Alembic Pharmaceuticals

All 9

Other Telmisartan recalls

All 6